首页> 美国卫生研究院文献>Microorganisms >Predictive Values of Serum Chlamydia trachomatis TroA and HtrA IgG Antibodies as Markers of Persistent Infection in the Detection of Pelvic Adhesions and Tubal Occlusion
【2h】

Predictive Values of Serum Chlamydia trachomatis TroA and HtrA IgG Antibodies as Markers of Persistent Infection in the Detection of Pelvic Adhesions and Tubal Occlusion

机译:血清沙眼衣原体TroA和HtrA IgG抗体作为持续感染标记物在盆腔粘连和输卵管阻塞检测中的预测价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IgG antibody testing (CAT) has been used as a screening test for tubal factor infertility (TFI), but as the CAT is only a marker of a past exposure to and not of late sequelae, the positive predictive value (PPV) of the test is low. The persistence of in the upper genital tract has been suggested as one of the key mechanisms in the development of TFI. Serum antibodies against TroA and HtrA, proteins expressed specifically during persistent infection, have been suggested as novel biomarkers for TFI diagnostics. We studied serum IgG antibody responses against TroA, HtrA and MOMP in 79 subfertile women, of whom 28 had laparoscopically proven TFI. We confirmed that the accuracy of CAT in diagnosing TFI is low, whereas TroA IgG and HtrA IgG are more accurate tests in detecting tubal occlusion and pelvic adhesions. However, the sensitivity and negative predictive value (NPV) of TroA IgG and HtrA IgG are still too low to justify their use as a screening test in clinical practice. Individual immunogenetic profiles combined with TroA and HtrA antibody responses might identify women with the highest risk for developing late complications after infection.
机译:IgG抗体检测(CAT)已被用作输卵管因素不育(TFI)的筛查检测,但由于CAT仅是过去接触过但不是后遗症的标志物,因此检测的阳性预测值(PPV)低。上生殖道的持续存在被认为是TFI发展的关键机制之一。有人提出针对TroA和HtrA的血清抗体是持续感染过程中特异性表达的蛋白质,已被认为是TFI诊断的新型生物标志物。我们研究了79名亚生育妇女的血清对TroA,HtrA和MOMP的IgG抗体应答,其中28名经腹腔镜检查证实为TFI。我们确认,CAT在诊断TFI中的准确性较低,而TroA IgG和HtrA IgG是检测输卵管阻塞和骨盆粘连的更准确测试。但是,TroA IgG和HtrA IgG的敏感性和阴性预测值(NPV)仍然太低,无法证明其在临床实践中用作筛选测试的合理性。结合TroA和HtrA抗体反应的个体免疫遗传学特征可能会确定感染后发生晚期并发症的风险最高的女性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号